homestoryboard18 News‘We like buying brands... especially in the OTC space,’ Nandini Piramal

‘We like buying brands... especially in the OTC space,’ Nandini Piramal

Nandini Piramal, executive director of Piramal Enterprises Ltd, on plans for the company’s growing consumer products division and its global brand positioning strategy for Piramal Pharma.

By Delshad Irani  Mar 15, 2022 3:21:46 PM IST (Updated)


Over the past few years, the Piramal Group has shifted its focus on building a consumer pull for its brands and aims to generate a turnover Rs 1000 crore in three years from its consumer products division. In an exclusive conversation with Storyboard18, Nandini Piramal, executive director of Piramal Enterprises Ltd, shares the company’s plans and ambitions for the CPD (consumer products division) business as it invests in marketing and onboards a host of celebrity brand endorsers. We dive into Piramal’s playbook - growth strategy, global positioning of the pharma company brand and future plans.
Edited excerpts.
You set a target of Rs 1000 crore turnover from the CPD business in the next three years. What are the key points in the plan to get there and what are the challenges that you foresee?
When we started this business and separated it from the broader pharma business it was only Rs 65 crore. So it's tiny. Over the last 10 years, we've actually grown it, we've invested in new brands. Our baby brand Little’s crossed Rs 100 crore in sales. We've now invested in categories that are bigger. The baby business alone, in India, is more than Rs 25,000 crore. And we’re a young country, we’re a growing country.
Our birth rate is at about 2 percent so we’ve got new consumers of our diapers and wipes coming in every day or every minute really. We're excited about that category. We're really excited about Lacto Calamine. It used to be just a lotion, we launched the sunscreen, aloe vera gel, face wash and cleansing wipes and we've actually really broadened the range. We think that will provide a solution to more people.